NCT04296474View on ClinicalTrials.gov

Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

June 20, 2022

Study Completion Date

July 1, 2022

Conditions
Allergic Rhinitis
Interventions
DRUG

ALK Alutard 5-grasses and birch

Intralymphatic injections

DRUG

ALK Diluent

intralymphatic injections

Trial Locations (3)

20502

Allergic Unit at the Department of Oto-Rhino-Laryngology at Skåne University Hospital Malmö, Malmo

221 85

Allergic Unit at the Department of Oto-Rhino-Laryngology at Skåne University Hospital Lund, Lund

141 86

ENT department, Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Lars Olaf Cardell

OTHER

NCT04296474 - Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass | Biotech Hunter | Biotech Hunter